A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction

Journal of Clinical Investigation

Volumn 95, Issue 3, 1995, Pages 1101-1108

  Stevens, Tracy L ^a   Burnett Jr , John C ^a   Kinoshita, Masahiko ^b   Matsuda, Yuzuru ^c   Redfield, Margaret M ^a  

^a MAYO CLINIC   (United States)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ANTAGONIST; CYCLIC GMP; HS 142 1; RENIN; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; HEART LEFT VENTRICLE FAILURE; MALE; NATRIURESIS; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SECOND MESSENGER; SODIUM ABSORPTION; SODIUM EXCRETION; SODIUM RETENTION;

EID: 0028966468     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117757     Document Type: Article

References (43)

1. Stevens, T. L., C. -M. Wei, L. L. Aahrus, D. M. Heublein, M. Kinoshita, Y. Matsuda, and J. C. Burnett, Jr. 1994. Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor inhibitor. Hypertension. 23:613-618.
2. Lee, M. E., W. L. Miller, B. S. Edwards, and J. C. Burnett, Jr. 1989. Role of endogenous atrial natriuretic factor in acute congestive heart failure. J. Clin. Invest. 84:1962-1966.
3. Drexler, H., C. Hirth, H. -P. Stasch, W. Lu, D. Neuser, and H. Just. 1990. Vasodilatory action of endogenous atrial natriuretic factor in a rat model of chronic heart failure as determined by monoclonal ANF antibody. Circ. Res. 66:1371-1380.
4. Wada, A., T. Tsutamoto, Y. Matsuda, and M. Kinoshita. 1994. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors. Circulation. 89:2232-2240.
5. Margulies, K. B., D. M. Heublein, M. A. Perrella, and J. C. Burnett, Jr. 1991. ANF-mediated renal cGMP generation in congestive heart failure. Am. J. Physiol. (Renal Fluid Electrolyte Physiol. 29) 260:F562-F568.
6. Francis, G. S., C. Benedict, D. E. Johnstone, P. C. Kirlin, J. Nicklas, C. Liang, S. H. Kubo, E. Rudin-Toretsky, S. Yusuf, and SOLVD Investigators. 1990. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the studies of left ventricular dysfunction (SOLVD). Circulation. 82:1724-1729.
7. Redfield, M. M., L. L. Aarhus, R. S. Wright, and J. C. Burnett, Jr. 1993. Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction. Circulation. 87:2016-2022.
8. Wright, R. S., R. R. Brandt, M. M. Redfield, L. L. Aarhus, and J. C. Burnett, Jr. 1993. Preservation of the renal natriuretic response to exogenous atrial natriuretic peptide in mild congestive heart failure. Am. J. Hypertens. 6:49a. (Abstr.)
9. Morishita, Y., T. Sano, K. Ando, Y. Saitoh, H. Kase, K. Yamada, and Y. Matsuda. 1991. Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor. Biochem. Biophys. Res. Commun. 176:949-957.
10. Morishita, Y., M. Takahashi, T. Sano, I. Kawamoto, K. Ando, H. Sano, Y. Saitoh, H. Kase, and Y. Matsuda. 1991. Isolation and purification of HS-142-1, a novel nonpeptide antagonist for ANP receptor, from Aureobasidium sp. Agric. Biol. Chem. 55:3017-3025.
11. Damiano, R. J., Jr., H. F. Tripp, K. W. Small, T. Asano, R. H. Jones, and J. E. Lowe. 1985. The functional consequences of prolonged supraventricular tachycardia. J. Am. Coll. Cardiol. 5:541. (Abstr.)
12. Margulies, K. B., F. L. Hildebrand, Jr., A. Lerman, M. A. Perrella, and J. C. Burnett, Jr. 1990. Increased endothelin in experimental heart failure. Circulation. 82:2226-2230.
13. Redfield, M. M., B. S. Edwards, M. D. McGoon, D. M. Heublein, L. L. Aarhus, and J. C. Burnett, Jr. 1989. Failure of atrial natriuretic factor to increase with volume expansion in acute and chronic congestive heart failure in the dog. Circulation. 80:651-657.
14. Perrella, M. A., T. R. Schwab, B. O'Murchu, M. M. Redfield, C. M. Wei, B. S. Edwards, and J. C. Burnett, Jr. 1992. Cardiac atrial natriuretic factor during evolution of congestive heart failure. Am. J. Physiol. (Heart Circ. Physiol. 31) 262:H1248-H1255.
15. Riegger, G. A. J., G. Liebau, M. Holzschuh, D. Witkowski, H. Steilner, and K. Kochsiek. 1984. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade. Am. J. Cardiol. 53:614-618.
16. Quinones, M. A., A. D. Waggoner, L. A. Reduto, J. G. Nelson, J. B. Young, W. L. Winters, Jr., L. G. Ribeiro, and R. R. Miller. 1981. A new simplified and accurate method for determining ejection fraction with 2-dimension echocardiography. Circulation. 64:744-753.
17. Thomsen, K., N. H. Holstein-Rathow, and P. P. Leussac. 1981. Comparison of three measures of proximal tubular reabsorption: lithium clearance, occlusion time, and micropuncture. Am. J. Physiol. 241:F348-F355.
18. Hayslett, J. P., and M. Kashgarian. 1979. A micropuncture study of the renal handling of lithium. Pflugers Arch. 380:159-163.
19. Fuhr, J. J., K. J. Kaczmarczyk, and C. D. Kruttgen. 1955. Eine ein fache colormetrische methode zur inulinbestimmung fur nieren-clearance-untersuchungen bei stoffwechselgesunden und diabetikern. Klin. Wochenschr. 33:729-730.
20. Burnett, J. C., Jr., D. C. Hu, D. W. Heser, D. M. Heublein, T. J. Opgenorth, J. P. Granger, and G. S. Reeder. 1986. Atrial natriuretic peptide elevation in congestive heart failure in man. Science (Wash. DC). 231:1145-1146.
21. Steiner, A. L., C. W. Parker, and D. M. Kipnis. 1972. Radioimmunoassay for cyclic nucleotidase. J. Biol. Chem. 247:1106-1113.
22. Haber, E., T. Koerner, L. B. Page, B. Kliman, and A. Purnode. 1969. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J. Clin. Endocrinol. Metab. 29:1349-1355.
23. Sando, J., and E. Haber. 1978. A direct microassay for aldosterone in plasma extracts. J. Clin. Endocrinol. Metab. 47:391-396.
24. Volpe, M., C. Tritto, N. De Luca, A. F. Mele, G. Lembo, S. Rubattu, M. Romano, P. De Carpora, I. Enea, B. Ricciardelli, B. Trimarco, and M. Condorelli. 1991. Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure. J. Clin. Invest. 88:1481-1489.
25. Packer, M. 1992. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J. Am. Coll. Cardiol. 20:248-254.
26. Cody, R. J., A. B. Covit, G. L. Schaer, J. H. Laragh, J. E. Sealey, and J. Feldschuh. 1986. Sodium and water balance in chronic congestive heart failure. J. Clin. Invest. 77:1441-1452.
27. Tsutamoto, T., T. Kanamori, N. Morigami, Y. Sugimoto, O. Yamaoka, and M. Kinoshita. 1993. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular bed of patients with chronic severe heart failure. Circulation. 87:70-75.
28. Shen, W.-Q., X. Xu, G. A. Zeballos, and T. H. Hintze. 1992. Ventricular tissue is not the primary source of plasma atrial natriuretic peptide during heart failure. Circulation. 86:I-544. (Abstr.)
29. Burnett, J. C., Jr., J. P. Granger, and T. J. Opgenorth. 1984. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am. J. Physiol. (Renal Fluid Electrolyte Physiol. 16) 247:F863-F866.
30. + antiport in proximal tubular brush border membrane: role of dopamine. Kidney. Int. 38:1133-1140.
31. Opgenorth, T. J., J. C. Burnett, Jr., J. P. Granger, and T. A. Scriven. 1986. Effects of atrial natriuretic peptide on renin secretion in nonfiltering kidney. Am. J. Physiol. (Renal Fluid Electrolyte Physiol. 19) 250:F798-F801.
32. Maack, T., D. N. Marion, M. J. Camargo, H. D. Kleinert, J. H. Laragh, E. D. Vaughan, Jr., and S. A. Atlas. 1984. Effect of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am. J. Med. 77:1069-1075.
33. Showalter, C. J., R. S. Zimmerman, T. R. Schwab, B. S. Edwards, T. J. Opgenorth, and J. C. Burnett, Jr. 1988. Renal response to atrial natriuretic factor is modulated by intrarenal antiotensin II. Am. J. Physiol. (Reg. Integ. Comp. Physiol. 23) 254:R453-R456.
34. Sano, T., Y. Morishita, Y. Matsuda, and K. Yamada. 1992. Pharmocological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats. J. Pharm. Exp. Ther. 260:825-831.
35. Ohyama, Y., K. Miyamoto, Y. Morishita, Y. Matsuda, Y. Saito, N. Minamino, K. Kangawa, and H. Matsuo. 1992. Stable expression of natriuretic peptide receptors: effects of HS-142-1, a non-peptide ANP antagonist. Biochem. Biophys. Res. Commun. 189:336-342.
36. Takayanagi, R., T. Inagami, R. Snajdar, T. Imada, M. Tamura, and K. Misono. 1987. Two distinct forms of receptors for atrial natriuretic factor in bovine adrenocortical cells. J. Biol. Chem. 262:12104-12113.
37. Imura, R., T. Sano, J. Goto, K. Yamada, and Y. Matsuda. 1992. Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors. Mol. Pharmacol. 42:982-990.
38. Sano, T., R. Imura, Y. Morishita, Y. Matsuda, and K. Yamada. 1992. HS-142-1, a novel polysaccharide of microbial origin, specifically recognizes guanylyl cyclase-linked ANP receptor in rat glomeruli. Life Sci. 51:1445-1451.
39. Matsuda, Y., T. Sano, R. Imura, J. Goto, and K. Yamada. 1992. Specific inhibition by a novel atrial natriuretic peptide (ANP) antagonist of ANP-induced relaxation of aorta through the inhibition of cyclic GMP production. J. Hypertension. 10(4):S77.
40. 1 cells. Biosci. Biotech. Biochem. 56(7):1041-1045.
41. Lerman, A., R. J. Gibbons, R. J. Rodeheffer, K. R. Bailey, L. J. McKinley, D. M. Heublein, and J. C. Burnett, Jr. 1993. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet. 341:1105-1109.
42. Gottlieb, S. S., M. L. Kukin, D. Ahern, and M. Packer. 1989. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J. Am. Coll. Cardiol. 13:1534-1539.
43. Motwani, J. G., C. C. Lang, M. J. Allen, H. F. Johnson, and A. D. Struthers. 1993. Dose-ranging effects of candoxatril on elimination of exogenous atrial natriuretic peptide in chronic heart failure. Clin. Pharmacol. Ther. 54:661-669.